Literature DB >> 19808295

Absence of exercise capacity improvement after exercise training program: a strong prognostic factor in patients with chronic heart failure.

Jean-Yves Tabet1, Philippe Meurin, Florence Beauvais, Hélène Weber, Nathalie Renaud, Gabriel Thabut, Alain Cohen-Solal, Damien Logeart, Ahmed Ben Driss.   

Abstract

BACKGROUND: Exercise training is established as adjuvant therapy for chronic heart failure, but the prognostic value of improvement in exercise capacity after exercise training has never been evaluated. METHODS AND
RESULTS: In this prospective bicentric study, all chronic heart failure patients with left ventricular ejection fraction <45% who underwent an exercise training program in a cardiac rehabilitation center between January 2004 and September 2006 were consecutively included. Improvement in exercise capacity was assessed by change in peak oxygen consumption (deltaPVo(2)) and in PVo(2) expressed as a percentage of predicted PVo(2) (delta%PPVo(2)) measured before and after the training program. We included 155 patients (54+/-12 years old, male 81%, left ventricular ejection fraction=29.5+/-7.1%). Patients underwent 20 (10-30) training sessions. PVo(2) and %PPVo(2) were significantly increased after the training program (14% and 13%, respectively, P<0.001 for both). After 16+/-6 months follow-up, 27 patients had a cardiac event (death [n=12], cardiac transplantation [n=5], hospitalization for acute heart failure [n=10]). Univariate analysis revealed that among 17 significant predictors of cardiac events, the 2 more powerful ones were level of B-type natriuretic peptide at baseline (P<0.0001) and improvement in exercise capacity as assessed by deltaPVo(2) and delta%PPVo(2) (P<0.0001). Multivariate analysis revealed B-type natriuretic peptide level and delta%PPVo(2) as only independent predictive factors of outcome (P=0.01). The risk ratio of cardiac events for nonresponse versus response to the training program (defined as median delta%PPVo(2)<6%) was 8.2 (P=0.0006).
CONCLUSIONS: Among patients with chronic heart failure, the lack of improvement in exercise capacity after an exercise training program has strong prognostic value for adverse cardiac events independent of classical predictive factors such as left ventricular ejection fraction, New York Heart Association class, and B-type natriuretic peptide level.

Entities:  

Mesh:

Year:  2008        PMID: 19808295     DOI: 10.1161/CIRCHEARTFAILURE.108.775460

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  16 in total

1.  Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training.

Authors:  Ann M Swank; John Horton; Jerome L Fleg; Gregg C Fonarow; Steven Keteyian; Lee Goldberg; Gene Wolfel; Eileen M Handberg; Dan Bensimhon; Marie-Christine Illiou; Marianne Vest; Greg Ewald; Gordon Blackburn; Eric Leifer; Lawton Cooper; William E Kraus
Journal:  Circ Heart Fail       Date:  2012-07-06       Impact factor: 8.790

Review 2.  Should high-intensity-aerobic interval training become the clinical standard in heart failure?

Authors:  Ross Arena; Jonathan Myers; Daniel E Forman; Carl J Lavie; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

3.  Exercise training in chronic heart failure.

Authors:  Catherine De Maeyer; Paul Beckers; Christiaan J Vrints; Viviane M Conraads
Journal:  Ther Adv Chronic Dis       Date:  2013-05       Impact factor: 5.091

4.  Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION).

Authors:  W Schuyler Jones; Robert Clare; Stephen J Ellis; James S Mills; David L Fischman; William E Kraus; David J Whellan; Christopher M O'Connor; Manesh R Patel
Journal:  Am J Cardiol       Date:  2011-05-10       Impact factor: 2.778

Review 5.  Revisiting the physiological effects of exercise training on autonomic regulation and chemoreflex control in heart failure: does ejection fraction matter?

Authors:  David C Andrade; Alexis Arce-Alvarez; Camilo Toledo; Hugo S Díaz; Claudia Lucero; Rodrigo A Quintanilla; Harold D Schultz; Noah J Marcus; Markus Amann; Rodrigo Del Rio
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

6.  Assessment for Exercise Prescription in Heart Failure.

Authors:  Marco Guazzi
Journal:  Card Fail Rev       Date:  2015-04

Review 7.  Exercise in the management of patients with chronic heart failure.

Authors:  Steven J Keteyian
Journal:  Curr Heart Fail Rep       Date:  2010-03

8.  The importance of daily physical activity for improved exercise tolerance in heart failure patients with limited access to centre-based cardiac rehabilitation.

Authors:  Noriaki Sato; Hideki Origuchi; Umpei Yamamoto; Yasuhiro Takanaga; Masahiro Mohri
Journal:  Exp Clin Cardiol       Date:  2012-09

Review 9.  Role and benefits of exercise in the management of patients with heart failure.

Authors:  Steven J Keteyian; Jerome L Fleg; Clinton A Brawner; Ileana L Piña
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

10.  Exercise intolerance in volume overload heart failure is associated with low carotid body mediated chemoreflex drive.

Authors:  David C Andrade; Esteban Díaz-Jara; Camilo Toledo; Karla G Schwarz; Katherin V Pereyra; Hugo S Díaz; Noah J Marcus; Fernando C Ortiz; Angélica P Ríos-Gallardo; Domiziana Ortolani; Rodrigo Del Rio
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.